Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price ...

Bayer upgraded to Buy at Goldman Sachs, saying risk/reward into H2 2025 looks positive and catalysts including upcoming ...

On Thursday, Goldman Sachs analyst James Quigley upgraded Bayer Aktiengesellschaft (OTC:BAYRY) to Buy from Neutral, while setting a price target of EUR 33. Quigley indicated that the stock’s ...

On Thursday, Goldman Sachs analysts upgraded Bayer AG (ETR:BAYGN) (BAYN:GR) (OTC: BAYRY) stock from Neutral to Buy. The new price target is set at €33.00, up from the previous €29.10.

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Find insight on Bayer and more in the latest Market Talks covering the Health Care sector.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

“Is David Solomon too big a jerk to run Goldman Sachs?” asked New York Magazine in an infamous 2023 portrayal. No, was the answer – apparently he’s just the right size for an $80 million ...